Phase-I/II study of bortezomib in combination with carboplatin and bevacizumab as first-line therapy in patients with advanced non-small-cell lung cancer (Q33400938)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Phase-I/II study of bortezomib in combination with carboplatin and bevacizumab as first-line therapy in patients with advanced non-small-cell lung cancer |
scientific article |
Statements
1 reference
Phase-I/II study of bortezomib in combination with carboplatin and bevacizumab as first-line therapy in patients with advanced non-small-cell lung cancer (English)
1 reference
Bilal Piperdi
1 reference
William V Walsh
1 reference
Kendra Bradley
1 reference
Zheng Zhou
1 reference
Venu Bathini
1 reference
Meredith Hanrahan-Boshes
1 reference
Lloyd Hutchinson
1 reference
Roman Perez-Soler
1 reference
1 June 2012
1 reference
1 reference
1032-1040
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference